RENALYTIX PLC - AMERICAN DEPOSITARY SHARES

Commencement of trading on OTCQB in the United States

08 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

11 Jul 2024 07:00:03 By Nasdaq GlobeNewswire

Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination

27 Jun 2024 18:30:18 By Nasdaq GlobeNewswire

Medicare Issues Final Coverage Determination for kidneyintelX.dkd

14 Jun 2024 07:00:11 By Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

15 May 2024 07:00:14 By Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15

09 May 2024 07:00:12 By Nasdaq GlobeNewswire

Renalytix Announces Financing with Expected Size of up to $4 Million

08 Apr 2024 07:00:23 By Nasdaq GlobeNewswire

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

14 Mar 2024 07:00:45 By Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024

15 Feb 2024 07:00:32 By Nasdaq GlobeNewswire

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

09 Feb 2024 09:00:49 By Nasdaq GlobeNewswire

New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease

10 Jan 2024 07:00:50 By Nasdaq GlobeNewswire

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

14 Nov 2023 07:00:24 By Nasdaq GlobeNewswire

Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14

07 Nov 2023 07:00:59 By Nasdaq GlobeNewswire

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

06 Oct 2023 07:00:19 By Nasdaq GlobeNewswire

Renalytix Reports Full Year Fiscal 2023 Results

28 Sep 2023 07:00:50 By Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28

25 Sep 2023 07:00:40 By Nasdaq GlobeNewswire

Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer

07 Sep 2023 07:00:27 By Nasdaq GlobeNewswire

Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

03 Aug 2023 07:00:29 By Nasdaq GlobeNewswire

Renalytix Announces Middle East Distribution Agreement with Vector Pharma

21 Jul 2023 07:00:08 By Nasdaq GlobeNewswire

Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions

07 Jul 2023 07:00:47 By Nasdaq GlobeNewswire